Qualcomm submitted concessions for a proposed US$38 billion acquisition of NXP Semiconductors as it attempts to ease EU antitrust concerns regarding the deal.
According to a notice on the European Commission (EC) website, Qualcomm submitted its proposals last Thursday October 5. The filing, however, did not reveal any details on what Qualcomm actually proposed.
The EC opened a full investigation into the deal in June amid concerns it could lead to high prices and reduced innovation in the semiconductor industry. Since then, the probe was suspended twice, once on June 30 and most recently on August 17, as the Commission waits on further information from Qualcomm.
It said it would provide a new deadline for a decision on the deal once Qualcomm had compiled with its request.
According to Reuters, the Commission is also expecting feedback from rival companies in the coming days.
In June, Qualcomm attempted to push through the deal through without offering any concessions, but appears to have changed its approach to address the watchdog’s concerns.
Qualcomm is looking to merge with the semiconductor player to bolster its proposition adjacent to its core mobile business, in areas including the internet of things and security applications.
Full Content: Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas